Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer

被引：0
|
作者：
Anja Thronicke
Megan L. Steele
Christian Grah
Burkhard Matthes
Friedemann Schad
机构：
[1] Forschungsinstitut Havelhöhe gGmbH,Institute of Health and Biomedical Innovation, School of Public Health and Social Work
[2] Queensland University of Technology,undefined
[3] Gemeinschaftskrankenhaus Havelhöhe,undefined
[4] Klinikum Brandenburg der Medizinischen Hochschule Brandenburg,undefined
来源：
BMC Complementary and Alternative Medicine | / 17卷
关键词：
Targeted therapy; Immune checkpoint inhibitors; PD-1; CTLA-4; Mistletoe; L.; Drug interaction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer
    Thronicke, Anja
    Steele, Megan
    Grah, Christian
    Matthes, Burkhard
    Schad, Friedemann
    PHYTOMEDICINE, 2019, 61
  • [2] Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer
    Thronicke, Anja
    Steele, Megan L.
    Grah, Christian
    Matthes, Burkhard
    Schad, Friedemann
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 17
  • [3] Clinical Safety of Combinational Therapy of Immune Checkpoint Inhibitors and Viscum Album L. in Patients with Advanced or Metastasized Cancer
    Thronicke, Anja
    Steele, Megan
    Grah, Christian
    Matthes, Burkhard
    Schad, Friedemann
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1295 - S1296
  • [4] Clinical safety of combined targeted and Viscum album L. therapy in oncological patients
    Thronicke, Anja
    Oei, Shiao Li
    Merkle, Antje
    Matthes, Harald
    Schad, Friedemann
    PHYTOMEDICINE, 2019, 61
  • [5] Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: A randomised clinical trial on overall survival
    Troeger, W.
    Galun, D.
    Reif, M.
    Schumann, A.
    Stankovic, N.
    Milicevic, M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (18) : 3788 - 3797
  • [6] Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival
    Ahlborn, M.
    Lordick, F.
    ONKOLOGE, 2014, 20 (04): : 376 - 377
  • [7] Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety
    Azoury, Said C.
    Straughan, David M.
    Shukla, Vivek
    CURRENT CANCER DRUG TARGETS, 2015, 15 (06) : 452 - 462
  • [8] Safety of Immune Checkpoint Inhibitors for Cancer Therapy in IBD Patients
    Llano, Ernesto M.
    Rubin, David T.
    Luke, Jason
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S406 - S407
  • [9] The safety and efficacy of lenvatinib combined with immune checkpoint inhibitors therapy for advanced hepatocellular carcinoma
    Wang, Yun
    Jiang, Man
    Zhu, Jingjuan
    Qu, Jialin
    Qin, Kang
    Zhao, Deze
    Wang, Li
    Dong, Lina
    Zhang, Xiaochun
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 132
  • [10] Adverse and expected drug reactions to therapy with mistletoe extracts (Viscum album L.) in cancer patients
    Steele, M. L.
    Axtner, J.
    Happe, A.
    Kroez, M.
    Matthes, H.
    Schad, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S183 - S184
12345